Lincoln Pharmaceuticals balance sheet

As of Sep 2026

Total assets: ₹964cr+12.8% on Sep 2025
Shareholders' equity: ₹812cr+13.4% on Sep 2025
Total debt: ₹3.4cr+5,022.2% on Sep 2025
Cash and investments: ₹266cr+16.0% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	190	190	182	179	150
	6.7	5.2	4.5	3.5	6.7
	1.1	0.9	0.4	0.3	0.3
	0.0	0.0	0.0	0.0	0.0
	90.3	107	106	65.8	59.3
	1.0	1.3	1.1	0.6	1.0
	91.4	108	107	66.4	60.4
	32.2	2.9	3.6	4.4	2.6
	321	307	297	254	220
	81.7	80.1	78.7	77.2	70.0
	245	209	174	139	91.3
	164	161	166	162	136
	21.3	21.5	13.4	5.7	5.1
	10.9	11.1	9.0	8.1	29.3
	84.0	80.9	35.3	38.4	23.2
	3.1	0.8	1.2	0.5	0.7
	528	484	399	353	286
	33.1	18.7	21.6	16.1	11.3
	643	583	500	447	367
	964	890	797	700	587
Equity
	20.0	20.0	20.0	20.0	20.0
	791	738	652	573	482
	812	758	672	593	502
	812	758	672	593	502
Liabilities
	6.4	6.4	5.4	3.6	4.7
	6.4	6.4	5.4	3.6	4.7
	0.8	1.8	0.7	0.1	0.0
	18.9	13.5	13.0	11.5	7.9
	26.1	21.7	19.1	15.2	12.7
	3.4	4.4	0.0	1.1	2.0
	95.5	84.9	84.9	72.4	51.2
	15.0	11.1	9.7	12.4	12.1
	114	100	94.6	85.9	65.3
	5.2	6.1	6.5	3.5	4.0
	3.2	1.7	0.0	0.1	0.9
	4.3	2.9	5.1	2.7	2.1
	127	111	106	92.3	72.3
	153	133	125	107	84.9
	964	890	797	700	587
Assets — additional as-filed lines
	0.0	0.0	0.7	0.0	0.0
Trade payables — MSME split
	11.7	6.9	8.7	—	—
	83.8	77.9	76.2	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

LINCOLN₹558.10

Lincoln Pharmaceuticals Limited

· Pharma & Health

₹ CrorePeersSIGACHI THEMISMED BAJAJHCARE AMRUTANJANJAGSNPHARM WANBURY AHCLMcap ₹1,118 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	150.2	179.0	181.5	190.0	189.8
+ Capital Work-in-Progress	6.7	3.5	4.5	5.2	6.7
+ Other Intangibles	0.3	0.3	0.4	0.9	1.1
+ Non-current Investments	0.0	0.0	0.0	0.0	0.0
+ Long-term Loans	59.3	65.8	106.0	106.9	90.3
+ Other Non-current Financial Assets	1.0	0.6	1.1	1.3	1.0
Non-current Financial Assets	60.4	66.4	107.1	108.3	91.4
+ Other Non-current Assets	2.6	4.4	3.6	2.9	32.2
Total Non-current Assets	220.2	253.6	297.1	307.3	321.1
Current Assets
+ Inventories	70.0	77.2	78.7	80.1	81.7
+ Current Investments	91.3	138.9	173.7	208.5	244.6
+ Trade Receivables	136.3	161.8	166.4	161.4	164.4
+ Cash & Cash Equivalents	5.1	5.7	13.4	21.5	21.3
+ Other Bank Balances	29.3	8.1	9.0	11.1	10.9
+ Short-term Loans	23.2	38.4	35.3	80.9	84.0
+ Other Current Financial Assets	0.7	0.5	1.2	0.8	3.1
Current Financial Assets	285.9	353.5	399.0	484.3	528.3
+ Other Current Assets	11.3	16.1	21.6	18.7	33.1
Total Current Assets	367.2	446.7	499.9	583.1	643.1
Total Assets	587.4	700.3	797.0	890.4	964.2
Equity
+ Equity Share Capital	20.0	20.0	20.0	20.0	20.0
+ Other Equity / Reserves	482.4	572.8	651.6	737.6	791.5
Equity — Owners of Parent	502.5	592.8	671.7	757.6	811.5
Total Equity	502.5	592.8	671.7	757.6	811.5
Liabilities
+ Other Non-current Financial Liab	4.7	3.6	5.4	6.4	6.4
Non-current Financial Liabilities	4.7	3.6	5.4	6.4	6.4
+ Provisions — Non-current	0.0	0.1	0.7	1.8	0.8
+ Deferred Tax Liabilities	7.9	11.5	13.0	13.5	18.9
Non-current Liabilities	12.7	15.2	19.1	21.7	26.1
+ Borrowings — Current	2.0	1.1	0.0	4.4	3.4
+ Trade Payables	51.2	72.4	84.9	84.9	95.5
+ Other Current Financial Liab	12.1	12.4	9.7	11.1	15.0
Current Financial Liabilities	65.3	85.9	94.6	100.4	113.9
+ Provisions — Current	4.0	3.5	6.5	6.1	5.2
+ Current Tax Liabilities	0.9	0.1	0.0	1.7	3.2
+ Other Current Liabilities	2.1	2.7	5.1	2.9	4.3
Current Liabilities	72.3	92.3	106.2	111.0	126.6
Total Liabilities	84.9	107.5	125.3	132.8	152.7
Total Equity & Liabilities	587.4	700.3	797.0	890.4	964.2
Assets — additional as-filed lines
+ Current Tax Assets	0.0	0.0	0.7	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	8.7	6.9	11.7
+ Dues to Other Creditors — Current	—	—	76.2	77.9	83.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.